These highlights do not include all the information needed to use BRIVIACT ® safely and effectively. See full prescribing information for BRIVIACT.
BRIVIACT ® (brivaracetam) tablets, for oral use
BRIVIACT ® (brivaracetam) oral solution
BRIVIACT ® (brivaracetam) injection, for intravenous use
Initial U.S. Approval: 2016
INDICATIONS AND USAGE
BRIVIACT is indicated as adjunctive therapy in the treatment of partial-onset seizures in patients 16 years of age and older with epilepsy. (1)
DOSAGE AND ADMINISTRATION
-
The recommended starting dosage is 50 mg twice daily. Based on individual patient tolerability and therapeutic response, the dosage may be
